These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 9122728)

  • 41. [Circulating prognosis markers in melanoma: proteomic profiling and clinical studies].
    Solassol J; Guillot B; Maudelonde T
    Ann Biol Clin (Paris); 2011; 69(2):151-7. PubMed ID: 21464007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.
    Taback B; Morton DL; O'Day SJ; Nguyen DH; Nakayama T; Hoon DS
    Recent Results Cancer Res; 2001; 158():78-92. PubMed ID: 11092035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced photoacoustic detection of melanoma cells using gold nanoparticles.
    McCormack DR; Bhattacharyya K; Kannan R; Katti K; Viator JA
    Lasers Surg Med; 2011 Apr; 43(4):333-8. PubMed ID: 21500228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study.
    Roland CL; Ross MI; Hall CS; Laubacher B; Upshaw J; Anderson AE; Lucci A
    Melanoma Res; 2015 Aug; 25(4):335-41. PubMed ID: 26011119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance.
    Nezos A; Lembessis P; Sourla A; Pissimissis N; Gogas H; Koutsilieris M
    Clin Chem Lab Med; 2009; 47(1):1-11. PubMed ID: 19055471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study.
    Cochran AJ; Wen DR; Morton DL
    Am J Surg Pathol; 1988 Aug; 12(8):612-8. PubMed ID: 3041850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular markers of circulating melanoma cells.
    Medic S; Pearce RL; Heenan PJ; Ziman M
    Pigment Cell Res; 2007 Apr; 20(2):80-91. PubMed ID: 17371435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of outcome for patients with cutaneous melanoma.
    Cochran AJ
    Pigment Cell Res; 1997 Jun; 10(3):162-7. PubMed ID: 9266604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression.
    Reid AL; Millward M; Pearce R; Lee M; Frank MH; Ireland A; Monshizadeh L; Rai T; Heenan P; Medic S; Kumarasinghe P; Ziman M
    Br J Dermatol; 2013 Jan; 168(1):85-92. PubMed ID: 23013138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of circulating tumor cells by photoacoustic flowmetry.
    Weight RM; Viator JA
    Methods Mol Biol; 2014; 1102():655-63. PubMed ID: 24259004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Skin lesions in melanoma and Kaposi's sarcoma. Case 1. Detection of circulating malignant cells by RT-PCR in a case of cutaneous melanoma in complete regression.
    Santini D; Tonini G; Vincenzi B; Murace R; Ferranti G; Baldi A
    J Clin Oncol; 2002 Mar; 20(5):1411-2. PubMed ID: 11870187
    [No Abstract]   [Full Text] [Related]  

  • 52. Detection of early micrometastases in malignant melanoma.
    Rankin EM
    Eur J Cancer; 1996 Sep; 32A(10):1627-9. PubMed ID: 8983265
    [No Abstract]   [Full Text] [Related]  

  • 53. Detection methods of circulating tumor cells in cutaneous melanoma: a systematic review.
    Rodic S; Mihalcioiu C; Saleh RR
    Crit Rev Oncol Hematol; 2014 Jul; 91(1):74-92. PubMed ID: 24530125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating biomarkers in malignant melanoma.
    Alegre E; Sammamed M; Fernández-Landázuri S; Zubiri L; González Á
    Adv Clin Chem; 2015; 69():47-89. PubMed ID: 25934359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Satellite metastases in malignant melanoma].
    Nödl F
    Arch Klin Exp Dermatol; 1970; 238(2):179-86. PubMed ID: 5474527
    [No Abstract]   [Full Text] [Related]  

  • 56. The prognostic role of detection of circulating melanoma cells in the blood.
    Dutcher JP
    J Clin Oncol; 2003 Mar; 21(5):757-9. PubMed ID: 12610168
    [No Abstract]   [Full Text] [Related]  

  • 57. Orthotopic model for the analysis of melanoma circulating tumor cells.
    Pícková M; Kahounová Z; Radaszkiewicz T; Procházková J; Fedr R; Nosková M; Radaszkiewicz KA; Ovesná P; Bryja V; Souček K
    Sci Rep; 2024 Apr; 14(1):7827. PubMed ID: 38570556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Occult lymphatic metastases in malignant melanoma of the skin.
    JOHNSON RE
    Ann Surg; 1957 Dec; 146(6):931-6. PubMed ID: 13488371
    [No Abstract]   [Full Text] [Related]  

  • 59. Identification of Plasma Lipid Alterations Associated with Melanoma Metastasis.
    Szász I; Koroknai V; Várvölgyi T; Pál L; Szűcs S; Pikó P; Emri G; Janka E; Szabó IL; Ádány R; Balázs M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Issues affecting molecular staging in the management of patients with melanoma.
    Palmieri G; Casula M; Sini MC; Ascierto PA; Cossu A
    J Cell Mol Med; 2007; 11(5):1052-68. PubMed ID: 17979882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.